Veraxa Biotech Holding AG (VRXAW) Accounts Payables (2024 - 2025)
Veraxa Biotech Holding AG (VRXAW) posted quarterly Accounts Payables of $1.7 million for Q4 2025, up 212.06% year-over-year from $557682.5 in Q4 2024, and up 212.06% quarter-over-quarter from $557682.5 in Q4 2024.
Veraxa Biotech Holding AG (VRXAW) Accounts Payables (2024 - 2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXAW) has reported Accounts Payables for 2 consecutive years, with $1.7 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Accounts Payables rose 212.06% year-over-year to $1.7 million; the TTM figure through Dec 2025 stood at $1.7 million (up 212.06% YoY), while the FY2025 annual figure was $1.7 million, up 212.06% from the prior year.
- Accounts Payables grew to $1.7 million in Q4 2025 per VRXAW's latest filing, from $557682.5 in the prior quarter.
- Across five years, Accounts Payables topped out at $1.7 million in Q4 2025 and bottomed at $557682.5 in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.74 Mn |
| Dec 31, 2024 | 557,682.51 |